Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF Versus Adefovir Dipivoxil for the Treatment of Presumed Pre-Core Mutant Chronic Hepatitis B

NCT00117676 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00117676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00117676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF Versus Adefovir Dipivoxil for the Treatment of Presumed Pre-Core Mutant Chronic Hepatitis B
Lead sponsor
Gilead Sciences
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2005
Completion date
January 31, 2016
Enrollment
382 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b